Literature DB >> 10759027

Cyclic ADP-ribose.

A H Guse1.   

Abstract

The Ca2+-mobilizing natural compound cyclic ADP-ribose was discovered in sea urchin egg homogenates. Recently the involvement of cyclic ADP-ribose in Ca2+ signaling has been demonstrated in diverse biological systems spanning protozoa, plants, and cells from invertebrate, mammalian, and human sources. ADP-ribosyl cyclases synthesize cyclic ADP-ribose. Several candidate proteins for these enzymes have been proposed, including membrane-bound NAD+ glycohydrolases such as CD38 and soluble enzyme activities from various tissues and cells. Ca2+ mobilization by cyclic ADP-ribose is believed to proceed via the ryanodine receptor/Ca2+ channel, probably via binding proteins for cyclic ADP-ribose. Several antagonistic derivatives of cyclic ADP-ribose have been synthesized, some of which have been successfully used to demonstrate the involvement of cyclic ADP-ribose in sea urchin egg fertilization, glucose-dependent insulin secretion in pancreatic beta-cells, and activation and proliferation of human T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759027     DOI: 10.1007/s001090000076

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  13 in total

1.  Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.

Authors:  C Cakir-Kiefer; H Muller-Steffner; N Oppenheimer; F Schuber
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

Review 2.  Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link?

Authors:  Akshata Moghe; Swati Joshi-Barve; Smita Ghare; Leila Gobejishvili; Irina Kirpich; Craig J McClain; Shirish Barve
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

3.  Modulation of endoplasmic reticulum Ca2+ store filling by cyclic ADP-ribose promotes inositol trisphosphate (IP3)-evoked Ca2+ signals.

Authors:  Michiko Yamasaki-Mann; Angelo Demuro; Ian Parker
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

4.  TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion.

Authors:  Kazuya Togashi; Yuji Hara; Tomoko Tominaga; Tomohiro Higashi; Yasunobu Konishi; Yasuo Mori; Makoto Tominaga
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

Review 5.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 6.  Mitochondria in cardiomyocyte Ca2+ signaling.

Authors:  Valeriy Lukyanenko; Aristide Chikando; W J Lederer
Journal:  Int J Biochem Cell Biol       Date:  2009-04-02       Impact factor: 5.085

7.  Expression profile of the transient receptor potential (TRP) family in neutrophil granulocytes: evidence for currents through long TRP channel 2 induced by ADP-ribose and NAD.

Authors:  Inka Heiner; Jörg Eisfeld; Christian R Halaszovich; Edith Wehage; Eberhard Jüngling; Christof Zitt; Andreas Lückhoff
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 8.  Pharmacological modulation of intracellular Ca(2+) channels at the single-channel level.

Authors:  P Koulen; E C Thrower
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.682

9.  An interbacterial NAD(P)(+) glycohydrolase toxin requires elongation factor Tu for delivery to target cells.

Authors:  John C Whitney; Dennis Quentin; Shin Sawai; Michele LeRoux; Brittany N Harding; Hannah E Ledvina; Bao Q Tran; Howard Robinson; Young Ah Goo; David R Goodlett; Stefan Raunser; Joseph D Mougous
Journal:  Cell       Date:  2015-10-08       Impact factor: 41.582

10.  Global mass spectrometry based metabolomics profiling of erythrocytes infected with Plasmodium falciparum.

Authors:  Theodore R Sana; D Benjamin Gordon; Steven M Fischer; Shane E Tichy; Norton Kitagawa; Cindy Lai; William L Gosnell; Sandra P Chang
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.